J. Misitzis

Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial

Christos Markopoulos, E. Tzoracoleftherakis, A. Polychronis et al. · Breast Cancer Research · 2010 · 79 citations · Full text

Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy

Christos Markopoulos, Urania Dafni, J. Misitzis et al. · Breast Cancer Research · 2009 · 41 citations · Full text

Effect of exemestane on the lipidemic profile of post-menopausal operable breast cancer patients following 5–7 years of adjuvant tamoxifen: preliminary results of the ATENA substudy

Christos Markopoulos, M. Chrissochou, Alexandra-Maria Michailidou et al. · Anti-Cancer Drugs · 2005 · 34 citations

Clinical experience of using oncotype DX as an additional treatment decision tool in early breast cancer – A retrospective analysis from 5 Greek institutions

Christos Markopoulos, Gr. Xepapadakis, Vasileios Venizelos et al. · European Journal of Surgical Oncology · 2012 · 13 citations

Preclinical Therapeutics, Surgical Oncology, Breast Oncology +8

Are Thyroid Hormone and Tumor Cell Proliferation in Human Breast Cancers Positive for HER2 Associated?

Iordanis Mourouzis, Alexandros Tzovaras, Basil Armonis et al. · International Journal of Endocrinology · 2015 · 12 citations · Full text